The Alfred Research Alliance brings together eight independent and diverse organisations to create a community of excellence in medical research and education in Melbourne, Australia. We share a commitment to furthering knowledge and translating our research into new and improved diagnoses, treatments and public health strategies.
The members of the Alfred Research Alliance are recognised leaders in their fields, known for their diversity, excellence in research, outstanding patient engagement and award-winning researchers and health practitioners.
Each organisation contributes distinct skills, expertise and perspective to create a vibrant research environment, while encouraging the sharing of skills, technology and know-how.
We actively foster collaboration – including with clinical researchers at The Alfred, many with joint appointments at our member universities and medical research institutes – because we know it helps us to ‘solve the unsolvable’ and bring new interventions to patients more quickly.
This underpins the Alliance’s commitment to connecting research, clinical care and public health, ensuring that our new thinking has real impact.
These are the eight members that make up the Alliance:
Alfred Health is a state-wide health service comprising The Alfred, Caulfield and Sandringham Hospitals, along with a large network of community programs and services.
The Alfred is one of Australia’s busiest hospitals, providing the most comprehensive range of adult specialist medical and surgical services in Victoria. The hospital is also a major tertiary referral teaching hospital with a commitment to research excellence and training.
The Alfred sits at the epicentre of the Alfred Research Alliance, keeping our work patient-centred and outcome driven. Co-location on this site provides the opportunity for vital collaboration within the Alliance, between Alfred Health’s practitioners and clinical researchers and our partner universities and institutes.
Two of Monash University’s largest schools are located at the Alfred precinct within the newly-formed Sub-Faculty of Translational Medicine and Public Health. Monash Central Clinical School is a major centre for clinical and biomedical research and education. Monash Public Health and Preventive Medicine is a world leader in public health oriented research and education, including clinical trials and clinical registries.
Our membership of the Alfred Research Alliance aligns with our objective of research translation through collaboration with fellow researchers and clinical partners. As part of the Alliance, we can seamlessly integrate our research expertise with that of the other members, promoting excellence in healthcare.
Baker Heart and Diabetes Institute is an independent, not-for-profit medical research facility established in 1926.
The Institute’s research is focused on the prevention, diagnosis and treatment of cardiovascular disease, diabetes and other related health disorders. This includes addressing the profound health disadvantage experienced by Aboriginal Australians, with a research facility in Alice Springs.
The Baker Institute’s work extends from the laboratory to wide-scale community studies. The breadth of clinical and research expertise ensures that the Institute is well placed to advance understanding of these diseases, and to translate scientific findings into new approaches to prevention, treatment and care.
Burnet Institute is an independent, not-for-profit medical research and public health organisation that believes in equity through better health.
By linking discovery-oriented and implementation research with public health action, Burnet makes a tangible and sustainable impact on health in both developed and developing countries.
These innovative multidisciplinary responses are helping to tackle diseases of global significance, particularly HIV and AIDS, hepatitis viruses, malaria, tuberculosis and emerging infectious diseases.
Our membership of the Alfred Research Alliance is aligned with our mission: To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
Deakin University’s School of Nursing and Midwifery and Alfred Health Nursing Services have a long-established research and education partnership.
Through that partnership, staff at the Deakin Centre for Quality and Patient Safety Research are able to conduct high-quality research programs in the areas of patient safety and knowledge translation. Deakin undergraduate and postgraduate students also complete clinical placements here for their nursing, allied health and health science degrees.
Our membership of the Alfred Research Alliance supports our objectives of improving patient and organisational outcomes through high quality research, strengthening research training and support for nursing staff, and facilitating the integration of research evidence into clinical practice.
The La Trobe University Clinical School at The Alfred integrates research, teaching and clinical practice in allied health and nursing.
The objectives of the School are to provide national and international research leadership, conduct clinical research that makes a difference to patient outcomes, promote interdisciplinary and inter-institutional collaboration in healthcare delivery and research, provide a centre of excellence for education in nursing and allied health, and lead the translation of best evidence into clinical practice.
It is these objectives which underpin our membership of the Alfred Research Alliance, allowing us to collaborate closely with on-site partners and contribute academic leadership in nursing and allied health research and education.
Nucleus Network is Australia’s only international multi-site dedicated phase I clinical research organisation, with an 80-bed facility strategically co-located at the Alfred precinct.
Established in 2004, Nucleus Network has conducted more than 700 phase I clinical trials, with 90% of clients being international pharmaceutical and biotech companies. Nucleus runs approximately 70 phase I studies per year, and around 30 of these are true first-in-human studies. Nucleus has extensive experience with both biologics and small molecule products across most therapeutic areas.
Our co-location within the Alfred Research Alliance precinct enables easy and convenient access to a range of ancillary services, providing a one-stop solution for clients.
360biolabs is Australia’s most comprehensive speciality laboratory services organisation for therapeutic, vaccine and diagnostics development. The company develop and conduct pharmacokinetic (PK) and pharmacodynamic (PD) assays across a wide variety of therapeutic areas, and provide extensive support services to ensure the success of preclinical studies and clinical trials.
The team at 360biolabs are driven by quality with internationally recognised ISO and GLP accreditation. Based within the laboratories at the Burnet Institute and with clients ranging from small biotechs to large multinational pharmaceutical companies, 360biolabs is able to support a broad range of research and development activity here at the Alfred Research Alliance.